The revenue stands at ₹3,080.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.80 per cent from ₹2,831.00 crore. This corresponds to a year-on-year *(YoY) growth of 27.80 per cent.
Operating Profit stands at ₹1,255.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 34.37 per cent from ₹934.00 crore. This corresponds to a year-on-year *(YoY) growth of 72.15 per cent.
PBDT stands at ₹1,313.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 21.24 per cent from ₹1,083.00 crore. This corresponds to a year-on-year *(YoY) growth of 55.38 per cent.
Profit Before Tax stands at ₹1,180.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 22.53 per cent from ₹963.00 crore. This corresponds to a year-on-year *(YoY) growth of 60.98 per cent.
Net Profit stands at ₹902.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.11 per cent from ₹751.00 crore. This represents a 65.50 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Divi's Lab. | 1.08% | -0.29% | 8.13% | 37.41% | 51.33% | 52.39% |
| Sun Pharma.Inds. | 0.16% | 0.78% | -1.07% | 1.78% | 4.37% | 12.58% |
| Torrent Pharma. | -0.08% | -3.13% | -3.13% | 8.48% | 12.29% | 35.12% |
| Zydus Lifesci. | 2.69% | 1.36% | 1.58% | 5.62% | 26.25% | 8.28% |
| Cipla | 1.15% | 0.76% | -3.94% | 1.45% | 8.45% | -12.86% |
Chairman & Independent Directo : Ramesh B V Nimmagadda
Executive Director & MD : Murali K Divi
Executive Director : N V Ramana
Executive Director / Whole Time Director / CEO : Kiran S Divi
ED / WTD - Commercial : Nilima Prasad Divi
Executive Director / Whole Time Director : S. Devendra Rao
Independent Non Exe. Director : S Ganapaty
Independent Non Exe. Director : Sunaina Singh
Independent Non Exe. Director : Kosaraju Veerayya Chowdary
Independent Non Exe. Director : Rajendrakumar Premchand Shah
Company Sec. & Compli. Officer : Satish Choudhury